Matinas BioPharma Inc. (MTNB)
AMEX: MTNB
· Real-Time Price · USD
2.31
0.66 (40.00%)
At close: Aug 15, 2025, 3:59 PM
2.42
4.99%
After-hours: Aug 15, 2025, 07:58 PM EDT
Matinas BioPharma Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 962K | 962K | -1.1M | -1.1M | -1.1M | n/a | 2.16M | 3.22M | 4.28M | 3.19M | 2.09M | 1.03M | -33.3K | 33.00 | 95.83K | 191.67K | 191.67K |
Cost of Revenue | 241K | 481K | 721K | 959K | 952K | 941K | 4.19M | 4.18M | 4.18M | 4.16M | 2M | 1.97M | 1.92M | 4.95M | 4.69M | 7.83M | 11.06M |
Gross Profit | -241K | -481K | -1.82M | -2.06M | -2.05M | -941K | -2.03M | -963.29K | 103.35K | -975.18K | 91.52K | -936.23K | -1.95M | -4.95M | -4.6M | -7.64M | -10.87M |
Operating Income | -16.2M | -20.16M | -22.01M | -23.76M | -24.08M | -23.77M | -23.36M | -22.69M | -22.45M | -24.59M | -25.82M | -27.24M | -26.1M | -24.73M | -24.51M | -23.24M | -24.21M |
Interest Income | n/a | n/a | n/a | n/a | 1K | 1K | 1K | 1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -20.16M | -24.33M | -21.13M | -22.91M | -23.25M | -22.94M | -21.26M | -20.67M | -20.53M | -21M | -24.06M | -25.44M | -24.31M | -23.28M | -22.92M | -21.54M | -22.36M |
Net Income | -20.08M | -24.25M | -21.13M | -22.91M | -23.25M | -22.87M | -17.59M | -16.99M | -16.85M | -13.91M | -20.58M | -21.96M | -20.83M | -23.28M | -22.92M | -21.54M | -22.36M |
Selling & General & Admin | 8.13M | 8.49M | 8.81M | 9.51M | 9.64M | 10.13M | 10.83M | 10.81M | 11.07M | 11.1M | 10.9M | 10.34M | 9.78M | 10.18M | 10.74M | 10.84M | 10.89M |
Research & Development | 8.07M | 11.43M | 12.72M | 13.78M | 13.96M | 14.49M | 14.69M | 15.1M | 15.67M | 16.68M | 17.05M | 17.97M | 16.32M | 14.58M | 13.87M | 12.58M | 13.51M |
Other Expenses | n/a | n/a | n/a | 79K | 178K | 251K | 339.25K | 261.24K | 165.11K | 102K | 28.32K | 68.73K | 64.44K | 122.87K | 256.3K | 370K | 527.42K |
Operating Expenses | 15.96M | 19.67M | 21.53M | 23.28M | 23.6M | 24.62M | 25.52M | 25.91M | 26.74M | 27.78M | 27.95M | 28.3M | 26.1M | 24.77M | 24.61M | 23.43M | 24.4M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | -240K | -480K | -480K | -480K | -240K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 20.64M | 24.59M | 22.01M | 23.76M | 24.08M | 24.86M | 25.52M | 25.91M | 26.74M | 27.78M | 27.95M | 28.3M | 26.1M | 24.77M | 24.61M | 23.43M | 24.4M |
Income Tax Expense | -80K | -80K | n/a | n/a | n/a | -73K | -3.67M | -3.68M | -3.68M | -7.08M | -3.48M | -3.48M | -3.48M | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 5.09M | 4.87M | 5.04M | 4.99M | 4.35M | 4.35M | 4.35M | 4.35M | 4.35M | 4.34M | 4.34M | 4.34M | 4.33M | 4.33M | 4.3M | 4.1M | 4.08M |
Shares Outstanding (Diluted) | 5.09M | 4.87M | 5.04M | 4.99M | 4.35M | 4.35M | 4.35M | 4.35M | 4.35M | 4.34M | 4.34M | 4.34M | 4.33M | 4.33M | 4.3M | 4.1M | 4.08M |
EPS (Basic) | -4.06 | -5.07 | -4.56 | -5.1 | -5.34 | -5.25 | -4.04 | -3.91 | -3.88 | -3.21 | -4.75 | -5.08 | -4.89 | -5.53 | -5.57 | -5.42 | -5.67 |
EPS (Diluted) | -4.06 | -5.07 | -4.56 | -5.1 | -5.34 | -5.25 | -4.04 | -3.91 | -3.88 | -3.21 | -4.75 | -5.08 | -4.89 | -5.53 | -5.57 | -5.35 | -5.6 |
EBITDA | -15.47M | -19.19M | -21.1M | -22.86M | -23.09M | -22.71M | -22.39M | -21.72M | -21.59M | -23.95M | -25.06M | -26.47M | -25.39M | -24.03M | -23.68M | -22.58M | -23.38M |
EBIT | -14.26M | -20.16M | -22.01M | -23.76M | -24.08M | -23.77M | -23.36M | -22.69M | -22.45M | -24.59M | -25.82M | -27.24M | -26.1M | -24.73M | -24.51M | -23.24M | -24.21M |
Depreciation & Amortization | 732K | 972K | 965K | 959K | 952K | 941K | 926.82K | 919.61K | 915.47K | 898K | 877.29K | 842.54K | 795.46K | 781.49K | 767.33K | 759.91K | 773.69K |